ASCVD Risk Estimator - American College of Cardiology Estimate patient’s 10-year ASCVD risk at an initial visit to establish a reference point Forecast the potential impact of different interventions on patient risk
Multilingual ASCVD Risk Estimator | English This Risk Estimator enables health care providers and patients to estimate 10-year, optimal, and lifetime risks for atherosclerotic cardiovascular disease (ASCVD)
Drug Comparison - American College of Cardiology Given the benefits of statins in ASCVD risk reduction, clinicians should partner with the patient to gain a thorough symptom history and determine if he or she is truly statin intolerant